Picture of Fresh Tracks Therapeutics logo

FRTX — Fresh Tracks Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMicro CapTurnaround

Brief: Brickell Biotech Reports Third Quarter 2021 Financial Results And Provides Corporate Update

Nov 9 (Reuters) - Brickell Biotech Inc  BBI.O :
    * BRICKELL BIOTECH REPORTS THIRD QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES CORPORATE UPDATE
    * Q3 REVENUE $100,000
    * QTRLY LOSS PER SHARE $0.16

Source text for Eikon:  ID:nGNX2t6Hqw 
Further company coverage:  BBI.O 

 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Fresh Tracks Therapeutics

See all news